Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
PORCINE PARVOVIRUS INACTIVATED K-22 STRAIN
Merial Animal Health Limited
QI09AA02
PORCINE PARVOVIRUS INACTIVATED K-22 STRAIN
Emulsion for Injection
POM: Prescription Only Medicine as defined in relevant national legislation
Porcine
porcine parvovirus
Immunological - Inactivated vaccine
Authorised
2002-11-06
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT PARVOVAX. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 HAI.U: q.s. to obtain HAI antibody titres of 1 log10 in guinea-pigs after administration of the vaccine. For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Emulsion for injection. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Breeder pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For active immunisation of breeder pigs (gilts, sows, boars) against porcine parvovirus, to reduce the number of stillbirths and mummified foetuses in vaccinates. The onset of immunity is obtained from 2 to 3 weeks after the primary vaccination. This immunity persists for up to one year. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Vaccinate only healthy animals. Vaccinate sows during lactation. Each 2-ml dose of vaccine contains: Inactivated porcine parvovirus, minimum 2.0 HAI.U Thiomersal, maximum 0.2 mg Oily adjuvant which includes light paraffin oil 449.6 to 488.2 mg Benzyl alcohol 10.56mg H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _1_ _6_ _/_ _0_ _2_ _/_ _2_ _0_ _1_ _7_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _5_ _8_ _5_ _9_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS None. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTRATING THE MEDICINAL PRODUCT TO ANIMALS Apply usual aseptic procedures. To the user: This product contains mineral o Read the complete document